![Pharmacist examining drug in a pharmacy setting – patient-focused research](https://images.unsplash.com/photo-1580281657529-557a6abb6387?crop=entropy&cs=tinysrgb&fit=max&fm=jpg&ixid=M3wxMTc3M3wwfDF8c2VhcmNofDZ8fCUyN3BhdGllbnQtZm9jdXNlZCUyMHJlc2VhcmNoJTI3fGVufDB8MHx8fDE3NjE4NTY4MDN8MA&ixlib=rb-4.1.0&q=80&w=1080
Alt: woman in white dress shirt and black pants standing near brown wooden shelf – patient-focused research
Title: Pharmacist examining drug – patient-focused research

Meta description: Explore Bristol Myers Squibb’s patient-focused research in rare disease therapeutics, from personalised medicine to community support across Spain, Europe & Latin America.

The Landscape of Rare Disease Biotech

Rare diseases affect millions worldwide, yet finding treatments often feels like searching for a needle in a haystack. Companies such as BioCryst and Bristol Myers Squibb (BMS) are racing to improve outcomes. Both invest in patient-focused research, but their approaches and scale differ.

Side-by-Side Comparison

BioCryst at a Glance

Hereditary Angioedema (HAE) expertise
Focuses on breaking new ground in HAE and other rare conditions.
Oral small-molecule and protein therapeutics
Innovative drug discovery rooted in structure-guided chemistry.
Culture of resilience
Employees act as owners, turning challenges into breakthroughs.

Limitations of BioCryst
– Narrow pipeline centred on a handful of rare diseases.
– Limited patient-focused research outside of HAE.
– Smaller global footprint in Europe and Latin America.

Bristol Myers Squibb’s Approach

BMS brings decades of global experience to rare diseases, backed by extensive clinical trials and robust patient-focused research.

Industry leader in innovative therapeutics.
Cutting-edge personalised medicine via our Personalized Medicine Program.
Comprehensive support through a Digital Patient Engagement Platform.
Awareness and Educational Campaigns uniting patients, caregivers, and healthcare professionals.

“Our patient-focused research drives everything we do. We listen, we learn, and we tailor solutions that fit individual lives.”

How BMS Excels in Patient-Focused Research

Holistic Personalisation
– The Personalized Medicine Program uses genetic insights to match treatments to each patient’s unique profile.
– Real-time data helps clinicians adjust therapies on the fly.
Engagement & Education
– Our Digital Patient Engagement Platform offers interactive tools, videos, and peer support groups.
– Patients learn about rare diseases and share experiences in a secure online community—boosting adherence and hope.
Empowerment through Knowledge
– Awareness campaigns in Spain, Europe, and Latin America raise patient rights and new treatment options.
– Caregivers and healthcare professionals benefit from tailored resources on chronic disease management.

Every step underpins our commitment to patient-focused research. We don’t just develop medicines—we build ecosystems that surround patients with the right tools and guidance.

Real-World Impact: Voices from the Community

Ana, living with a rare blood disorder in Spain, struggled to find accurate information. After joining our digital platform, she connected with specialists and received personalised therapeutic advice. The result? Better symptom control and regained independence.

Carlos, a neurologist in Colombia, uses our educational modules to train nurses on new treatment pathways. He praises BMS’s dedication to providing clear, evidence-backed resources.

Their stories highlight how patient-focused research translates into real-life gains.

Bridging Gaps in Rare Disease Care

Accessibility
BMS’s network spans major healthcare centres in Europe and Latin America—ensuring patients can access groundbreaking therapies.
Affordability
Partnerships with advocacy groups help reduce costs and improve reimbursement pathways.
Innovation
Continuous investment in R&D means our pipeline keeps growing—tackling more rare diseases every year.

By placing patient-focused research at the core, BMS closes the loop between lab discovery and patient well-being.

Driving the Future of Rare Disease Therapeutics

The global biopharmaceutical market is booming, yet patient-centred innovation remains rare. Bristol Myers Squibb stands out by weaving patient-focused research into every facet: discovery, development, delivery, and digital engagement.

Whether you’re a chronic disease patient, a healthcare professional, or a caregiver, our integrated approach offers:

Personalised treatment strategies
Ongoing support and education
A truly collaborative community

Ready to learn more?

Experience the next level of rare disease care.
Visit Bristol Myers Squibb today to explore our full range of patient-focused research initiatives and therapeutic programmes.

Discover more at Bristol Myers Squibb